CHARLES RIVER Aktie

 

Conference Call to be Webcast Live at 10:00 a.m. ETBOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company will webcast its second-quarter 2025 financial results conference call on Thursday, July 31, 2025 at 10:00 a.m. ET. The conference call will be hosted by President and Chief Executive Officer Paul Maleh and Chad Holmes, CRA's Chief Corporate Development Officer and interim Chief Financial Officer. To listen to a live webcast of the call, please visit the “Investor Relations” section of CRA's website at http://www.crai.com. To listen to the call via telephone, dial (877) 709-8155 or (201) 689-8881. Prior to the call, CRA will post the press release announcing its financial results and supplemental financial information, including prepared CFO remarks, on the “Investor Relations” section of its website. An archived version of the webcast, press release, and finan...

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Dr. Gene Tien has joined CRA as a vice president in the Transfer Pricing Practice. "We are pleased to welcome Gene to our team," said Paul Maleh, President and Chief Executive Officer of Charles River Associates. "Gene's extensive expertise in transfer pricing and his ability to provide strategic advice to multinational clients will be invaluable in deepening our capabilities in this critical area." Rebel Curd, Practice Leader of the Transfer Pricing Practice, added, "Gene's understanding of intercompany pricing and his innovative approach to solving complex tax issues will be a tremendous asset to our clients. We are excited to have him on board and look forward to the contributions he will make to our practice." Dr. Tien brings extensive experience in working with global multinationals on intercompa...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Dr. Josh Sherman has rejoined CRA as Vice President in the Antitrust & Competition Practice. “We are thrilled to welcome Josh back to our team," said Paul Maleh, President and Chief Executive Officer of Charles River Associates. "Josh's deep expertise and proven track record in consulting, government, and academia will enhance our ability to serve our clients at the highest levels.” Margaret Sanderson, Practice Leader of the Antitrust & Competition Practice, added, "Josh's deep understanding of competitive dynamics and his innovative approach to economic analysis will be a tremendous asset to our clients. We are excited for his return to CRA and look forward to the significant contributions he will make to our practice." Dr. Sherman provides expert testimony and economic analysis in single-firm and multi-fi...

Team prepares for commercialization bolstered by START Program and regulatory recognition NEW YORK, July 8, 2025 /PRNewswire/ -- Myrtelle Inc. ("Myrtelle" or the "Company"), a pioneering clinical-stage gene therapy company dedicated to revolutionizing treatment for neurodegenerative......

CRAI boosts dividends and buybacks amid strong niche demand, but rising costs and a slipping current ratio tighten its liquidity outlook....

Despite Charles River Laboratories' weak performance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about its prospects....

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Graham Ross has joined CRA as Vice President and Global Chief Marketing Officer. Mr. Ross will be based in CRA's Toronto office. “I am excited to welcome Graham to the CRA team,” said CRA President and Chief Executive Officer Paul Maleh. “Graham is a distinguished marketing and business development executive with over 20 years of experience in professional services, particularly in the legal sector. Graham brings a strong analytical skill set and a data-driven approach to marketing to CRA.” “Throughout his career, he's demonstrated the ability to develop bespoke strategies to drive growth, deepen existing client relationships, and bring in new business. In addition to his legal experience, Graham has a background in consulting, having worked with a range of organizations to enhance their marketing and business developmen...

Seasoned global healthcare executive to lead next phase of growth for ResonantLEESBURG, Va. & BUFORD, Ga.--(BUSINESS WIRE)--Resonant Clinical Solutions (“Resonant” or the “Company”), a global provider of outsourced clinical trial solutions today announced the appointment of Dr. Christophe Berthoux as its Chief Executive Officer, effective immediately. Berthoux brings more than three decades of leadership experience in the pharmaceutical services industry, including senior roles across clinical research organizations, preclinical services, and patient recruitment solutions. Most recently, Berthoux served as CEO of private equity-backed NAMSA, where he meaningfully scaled the business through a combination of organic and M&A-driven growth. Prior to NAMSA, he held CEO roles at Synexus, a patient recruitment business acquired by PPD, and CitoxLab, which was acquired by Charles River Laboratories. Earlier in his career, Berthoux spent nearly two decades at Charles River Laboratories in senior leadershi...

David Hagerman Named Chief Financial Officer; Jeanine Falinski Promoted to Senior Vice President of Commercial DevelopmentNEW YORK--(BUSINESS WIRE)--Clinilabs, LLC, a leading full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and medical technology development, today announced the appointments of David Hagerman as Chief Financial Officer (CFO) and Jeanine Falinski as Senior Vice President of Commercial Development. These strategic additions to the executive team underscore Clinilabs' commitment to strengthening its leadership and commercial capabilities in support of continued growth. David Hagerman brings over 25 years of financial leadership experience across the life sciences and IT sectors. As CFO, he will oversee all financial operations and play a key role in driving long-term strategic and financial performance. Prior to joining Clinilabs, Mr. Hagerman served as CFO at X-Chem and held senior leadership roles at Charles River Laboratories and Parexel...

CRL and CHDI Foundation extend their Huntington's disease partnership, boosting integration and global flexibility in drug discovery....

Charles River Laboratories stock has notably lagged behind the broader market over the past year, yet analysts remain moderately optimistic about the stock's prospects....

CRAI stock rises 16% in a month, backed by rising earnings, growing dividends, and steady buybacks despite a tight labor market and liquidity concerns....

CRL stays on investors' radars due to the strength of partnerships and segmental prospects....

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Kurt G. Strunk has joined CRA's Energy Practice as a Vice President. Mr. Strunk will be based in CRA's New York City office. “I am pleased to welcome Kurt to the CRA team,” said CRA President and Chief Executive Officer Paul Maleh. “He has more than three decades of experience advising clients on complex issues at the intersection of energy economics, government regulation, and finance. His addition strengthens CRA's ability to support clients navigating some of the most pressing challenges in today's energy landscape and reflects our continued investment in top-tier talent to address the accelerating transformation of the energy sector.” “Kurt brings a wealth of knowledge and a strong track record of thought leadership in utility economics and regulatory strategy,” said Jim McMahon, CRA Vice President and leader of ...

Massaro, George - Aufsichtsrat - Tag der Transaktion: 2025-05-15...

Laplume, Joseph W. - Vorstand - Tag der Transaktion: 2025-05-13...

Massaro, George - Aufsichtsrat - Tag der Transaktion: 2025-05-14...

Examine Charles River's (CRL) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock....

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Viktor Tsyrennikov has joined CRA's Financial Economics Practice as a Vice President. “I am pleased to welcome Viktor to the CRA team,” said CRA President and Chief Executive Officer Paul Maleh. “He is an accomplished PhD economist and trusted advisor to financial institutions, with extensive experience in solving complex risk management and addressing regulatory challenges.” “Viktor has a proven track record in developing next-generation business-decision and risk-management systems, based on advanced statistics and AI, leveraging his deep expertise in financial markets, regulation, and analytics. With years of experience spanning industry, policy, and academia, he offers a unique perspective that combines high-level strategic thinking with hands-on management expertise,” said Marsha Courchane, CRA Vice President and l...